NEUROGASTRX
Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders.
NEUROGASTRX
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2012-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.neurogastrx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
105 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
PED-KRB LLC
PED-KRB, LLC is a pharmaceutical company.
Phapros
Phapros is a pharmaceutical company.
Renovo Research
Renovo is a pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Samsara BioCapital
Samsara BioCapital investment in Series B - Neurogastrx
Vivo Capital
Vivo Capital investment in Series B - Neurogastrx
RTW Investments LLC
RTW Investments LLC investment in Series B - Neurogastrx
Marshall Wace
Marshall Wace investment in Series B - Neurogastrx
5AM Ventures
5AM Ventures investment in Series B - Neurogastrx
venBio Partners
venBio Partners investment in Series B - Neurogastrx
OrbiMed
OrbiMed investment in Series B - Neurogastrx
5AM Ventures
5AM Ventures investment in Series A - Neurogastrx
venBio Partners
venBio Partners investment in Series A - Neurogastrx
OrbiMed
OrbiMed investment in Series A - Neurogastrx
Official Site Inspections
http://www.neurogastrx.com
- Host name: qs4476.pairsite.com
- IP address: 66.39.152.92
- Location: Pittsburgh United States
- Latitude: 40.4236
- Longitude: -79.9825
- Metro Code: 508
- Timezone: America/New_York
- Postal: 15203
More informations about "Neurogastrx"
Home - Neurogastrx, Inc.
Neurogastrx, Inc. is a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) …See details»
About Us - Neurogastrx, Inc.
Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system.See details»
Neurogastrx Org Chart - The Org
Explore Neurogastrx's org chart, teams, open roles, and company details. View executives, board members, related companies, and more.See details»
Neurogastrx - Crunchbase Company Profile & Funding
Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders. An oral, small molecule dopamine D2 receptor …See details»
Neurogastrx Company Profile 2024: Valuation, Funding
Developer of specialty therapies designed to treat gastrointestinal disorders affecting the enteric nervous system.See details»
Neurogastrx, Inc. - LinkedIn
We are a privately held, late clinical-stage biopharmaceutical company that is focused on identifying and developing therapies for patients suffering from serious gastrointestinal (GI) diseases.See details»
Neurogastrx, Inc. Company Profile | Woburn, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Neurogastrx, Inc. of Woburn, MA. Get the latest business insights from Dun & Bradstreet.See details»
Neurogastrx - VentureRadar
Website: http://www.neurogastrx.com/ Develops transformative therapies for gastrointestinal disorders affecting the enteric nervous system, with a lead compound targeting antiemetic …See details»
Neurogastrx Company Profile: Overview and Full News Analysis
Neurogastrx, Inc. is a Massachusetts-based privately held, late clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients suffering from serious …See details»
Neurogastrx assembles ex-Ironwood team with $60M …
Aug 26, 2021 · Neurogastrx thinks its late-stage acid reflux drug and another midstage gastrointestinal treatment can beat out existing mainstay therapies and has convinced investors to pump $60 million to get...See details»
Our Values - Neurogastrx, Inc.
Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system.See details»
Neurogastrx Secures $60 Million in Series B Financing and Expands ...
Aug 26, 2021 · WOBURN, Mass.-- ( BUSINESS WIRE )--Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) …See details»
Neurogastrx Secures $60 Million in Series B Financing and Expands ...
WOBURN, Mass., August 26, 2021-- Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced …See details»
Neurogastrx Company Profile - Office Locations, Competitors
Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. Its lead product is under development for the treatment of …See details»
Neurogastrx reels in $45M series A for gastroparesis med
Jan 5, 2018 · 5AMVentures, OrbiMed Advisors and venBio Partners led a $45 million series A round for Neurogastrx, which is working on treatments for gastrointestinal diseases by …See details»
Neurogastrx Announces Agreement with Daewoong …
Jun 8, 2021 · Neurogastrx, Inc. is a privately held specialty pharmaceutical company developing transformative therapies to advance the treatment of GI disorders for which meaningful …See details»
Our Company - Neurogastrx, Inc.
Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system.See details»
Neurogastrx Secures $60 Million in Series B Financing and Expands ...
Woburn, MA – August 26, 2021 – Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced …See details»
GLP-1 side effect treatment data released by Neurogastrx
Oct 16, 2024 · Neurogastrx believes its drug could treat one of the most troublesome side effects of one of the industry's biggest blockbusters. On Wednesday, the Boston-area biotech said …See details»
Newsroom - Neurogastrx, Inc.
Jan 4, 2018 · Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous …See details»